miltefosine has been researched along with palmitic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brun, R; Carballeira, NM; Herman, R; Kappe, SH; Lauinger, IL; Perozzo, R; Sanabria, D; Tarun, A; Tasdemir, D; Zloh, M | 1 |
| Balaña-Fouce, R; Carballeira, NM; Cartagena, M; Prada, CF; Reguera, RM; Sanabria, D; Tasdemir, D | 1 |
| Bala, V; Chhonker, YS | 1 |
1 review(s) available for miltefosine and palmitic acid
| Article | Year |
|---|---|
Recent developments in anti-Trichomonas research: An update review.
Topics: Antiparasitic Agents; Biological Products; Dose-Response Relationship, Drug; Humans; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship; Trichomonas; Trichomonas Infections | 2018 |
2 other study(ies) available for miltefosine and palmitic acid
| Article | Year |
|---|---|
2-Hexadecynoic acid inhibits plasmodial FAS-II enzymes and arrests erythrocytic and liver stage Plasmodium infections.
Topics: Alkynes; Antimalarials; Binding Sites; Cell Line, Tumor; Computer Simulation; Erythrocytes; Fatty Acid Synthase, Type II; Fatty Acids, Unsaturated; Humans; Kinetics; Liver; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins | 2010 |
2-Alkynoic fatty acids inhibit topoisomerase IB from Leishmania donovani.
Topics: Alkynes; Animals; Antiprotozoal Agents; Cell Line; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Humans; Leishmania donovani; Macrophages; Mice; Mice, Inbred BALB C; Molecular Structure; Parasitic Sensitivity Tests; Rats; Structure-Activity Relationship; Topoisomerase I Inhibitors; Trypanosoma brucei rhodesiense; Trypanosoma cruzi | 2012 |